Nanobiosystems for Antimicrobial Drug-Resistant Infections
The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or...
Main Authors: | Foteini Gkartziou, Nikolaos Giormezis, Iris Spiliopoulou, Sophia G. Antimisiaris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/5/1075 |
Similar Items
-
Antimicrobial Nanoparticles: applications and mechanisms of action
by: SSN Fernando, et al.
Published: (2018-05-01) -
Genes on the Move: In Vitro Transduction of Antimicrobial Resistance Genes between Human and Canine Staphylococcal Pathogens
by: Sian Marie Frosini, et al.
Published: (2020-12-01) -
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
by: Ketki Bhise, et al.
Published: (2018-07-01) -
Antimicrobial Drugs in Fighting against Antimicrobial Resistance
by: Guyue eCheng, et al.
Published: (2016-04-01) -
Impact of the Novel Prophage ϕSA169 on Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection
by: Liang Li, et al.
Published: (2020-06-01)